Volume 22 Number 4

This issue of EuroIntervention contains a State-of-the-Art on adjunctive pharmacological strategies for residual risk; a clinical consensus statement on day-case PCI; original research on the timing of aspirin discontinuation in ACS; 7-year outcomes in COMPARE-ABSORB; the PINNACLE-I trial; a Flashlight on a novel spacer for tricuspid regurgitation treatment; news from PCR; and more...

In this issue of EuroIntervention

A State-of-the-Art on adjunctive pharmacological strategies for residual risk; a consensus statement on day-case PCI; aspirin discontinuation timing in ACS; 7-year outcomes in COMPARE-ABSORB; the PINNACLE-I trial; a novel spacer for tricuspid regurgitation treatment; news from PCR; and more

Capodanno D

free

Viewpoint

PCR: a new era dawns

Prendergast B

free

State of the art

Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation

Oshima A, Serruys P, Garg S, McEvoy J, Wood D, Doenst T, Taggart D, Puskas J, Shajahan A, Sharif F, Miyashita K, Tobe A, Tsai T, Revaiah P, Dunne F, Mehran R, Budoff M, Kastelein J, Stroes E, Khamis R, Koenig W, Onuma Y

10.4244/EIJ-D-25-00598

free

Consensus Document

Day-case percutaneous coronary procedures. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology (ESC) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC

Toth G, Amabile N, Barbato E, Borregaard B, Buszman P, Cuisset T, Gilard M, James S, Al-Lamee R, Mashayekhi K, Regazzoli D, Sarno G, Siller-Matula J, Brugaletta S, Stefanini G

10.4244/EIJ-D-25-00326

free

Original Research

Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials

Lee J, Lee J, Kim SY, Jeon HS, Lee J, Ahn SG, Lee Y, Lee S, Ahn C, Kim J, Kim B, Ko Y, Choi D, Hong M, Jang Y, Hong S, Youn YJ

10.4244/EIJ-D-25-00832

Editorial comment

Aspirin discontinuation after ACS: timing the transition to ticagrelor monotherapy

Gragnano F, Calabrò P

10.4244/EIJ-D-25-01330

free

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial

Smits P, Wlodarczak A, Chevalier B, West N, Gori T, Abdel-Wahab M, Barbato E, Esposito G, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Tijssen J, Rademaker-Havinga T, Serruys P, Morice M, Onuma Y, Geuns R, behalf of the COMPARE-ABSORB trial investigators o

10.4244/EIJ-D-25-00778